Endothelin: a new challenge.
Doherty
A M
AM
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
D000595:Amino Acid Sequence; D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000378:metabolism; D002317:Cardiovascular Agents; D000072396:Endothelin-Converting Enzymes; D016232:Endothelins / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008666:Metalloendopeptidases; D008969:Molecular Sequence Data; D011956:Receptors, Cell Surface / Q000378:metabolism; D017466:Receptors, Endothelin; D013329:Structure-Activity Relationship
D002317:Cardiovascular Agents; D016232:Endothelins; D011956:Receptors, Cell Surface; D017466:Receptors, Endothelin; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes